Prophylactic OKT3 in renal retransplantation.
Cardella
C J
CJ
Division of Nephrology, University of Toronto, Ontario, Canada.
Blake
P
P
Cattran
D
D
Cole
E
E
D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000209:etiology; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D051379:Mice; D008875:Middle Aged; D016853:Muromonab-CD3; D011183:Postoperative Complications / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D012086:Reoperation
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3